03/09/2021
CBS News reports on our contactless clinical trial for COVID-19 treatment:
The race to find vaccines for COVID-19 has dominated the headlines, but there's been less news about how to keep people with COVID out of the hospital.
Tonight, we're going to tell you a story about one possible treatment. It's called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder.
Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill.
-----
Click below to watch or read the full report:
Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19.
